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Cross-sectional surveys depend on retrospective health transition questions (HTQ) to 
estimate recent changes in health status. This paper assesses the validity of the SF-36 
HTQ and calibrates its categories against change assessed prospectively on the SF-36 
domain scales in a subgroup known to have experienced clinically important change 




Adults (n =9,649) from a longitudinal population survey completed the SF-36 in 2001 
and 2002. Prospective measures were calculated as mean changes in SF-36 scale 
scores adjusted for age and gender, and also expressed as standardised response 
means. 
 
Comparison groups were those who had developed a long-term health condition since 





Those with a new condition and those without a new condition but who described 
their health as ‘somewhat worse’ than a year ago had comparable declines in health 
status on all domain scales except role physical, where those with a new condition 




This analysis demonstrates the validity and limitations of the HTQ as a measure of 
change in population studies The calibration is useful for interpreting the meaning of 
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Cross sectional studies rely on retrospective recall to identify and quantify recent 
changes in respondents’ health status. The short form 36 item (SF-36) survey is a 
health status instrument that includes a global health transition question (HTQ) 
that asks respondents to rate their general health compared with one year ago, 
with five categories of response, ‘Much better’, ‘Somewhat better’, ‘About the 
same’, ‘Somewhat worse’, ‘Much worse’ [1]. For example, the Australian 
National Health Survey, a cross-sectional population survey, included the HTQ as 
part of the full SF-36 in 1996, then as a stand alone item in 2001 [2]. In principle, 
such a brief retrospective item can add value to cross-sectional surveys where 
there is no opportunity for follow-up by identifying groups of subjects who have 
experienced a recent change in health status. However, such an item is useful only 
if it is a valid measure of prospective change in health, and if its magnitude is 
interpretable in clinically meaningful terms. 
 
There is a body of work establishing the validity of the SF-36 multi-item scales in 
population studies [1, 3-5]. However the validity of the SF-36 retrospective HTQ 
has received relatively little attention. The issues of reliability and validity of a 
global single item retrospective measure of change have been described by 
Norman et al (1997)[6] who point out that inter-item consistency, the usual test of 
reliability for multi-item scales, is not possible for single items. They also 
describe the problem of ‘present state bias’ where subjects are inclined to judge 
their change in health status in relation to their present health state; respondents 
with good health at follow-up are more likely to assume that their health has 
recently improved, and respondents with poor health at follow-up are more likely 
to assume that it has worsened. A number of studies have demonstrated present 
state bias in global retrospective transition questions [6, 7]. A more recent study 
has found that present state bias may be most pronounced when using a single 
global transition item and is ameliorated by using multi-item retrospective scales 
[8]. In terms of validity, it has been argued that the HTQ has face validity as a 
measure of subjectively meaningful change from the patient’s perspective, as seen 
in the routine use of retrospective report in clinical decision making [7]. 
 
Although a HTQ is arguably less well-validated than multi-item scales, it has been 
common practice to use a HTQ as an external ‘anchor’ against which to calibrate 
the responsiveness of the scales of health status instruments [7, 9, 10]. In 
particular retrospective questions such as the HTQ have been used to ascertain the 
magnitude of the minimal clinically important change (MCID) measured by 
prospective changes in scale scores of health status instruments [11]. The MCID 
is defined by the smallest category of the retrospective HTQ (somewhat 
better/worse) and assumes that the HTQ represents true change [6]. The term 
‘minimal clinically important difference’ however includes three problematic 
assumptions in its terminology that need clarification. Firstly the term MCID 
assumes that the respondent would consider any detectable change to be an 
important change. Yet a subject may detect and report changes that he/she does 
not necessarily deem to be important[12]. A second and related problem is the 
dependence of the MCID on the scale of available response categories on the 




produce different MCIDs [12]. Thirdly the term MCID assumes that the HTQ is a 
proxy for an actual clinical change when in fact the HTQ itself is a subjective 
measure of change. The magnitude of actual clinical change measured by the 
HTQ remains unclear and is the focus of this paper. 
 
To avoid problems of terminology, we use the more accurate term ‘minimal 
detectable difference’ (MDD) to describe the change in health status reported by 
the HTQ [13, 14]. The MDD that respondents can report with the HTQ 
corresponds to the categories ‘somewhat worse’ and ‘somewhat better’ health 
than a year ago. Applying the term MDD to the HTQ will then allow us to define 
our measure of actual clinical change without confusion in the use of terms. 
 
To our knowledge little has been done to ascertain the clinical meaning of the 
categories of the HTQ. Yet understanding the magnitude of clinical change 
associated with the MDD would make the HTQ a much more useful benchmark 
of change in health status. This question of the clinical meaning of the HTQ can 
be approached by using a measure of known clinical change which is external to 
the health status instrument and which occurred during the period covered by the 
HTQ. The HTQ response categories can then be calibrated against the anchor by 
comparing the relative size of prospective change in scale scores. 
 
The Household Income and Labour Dynamics in Australia (HILDA) study 
provides an opportunity for exploring the clinical meaning of the HTQ, since it is 
a longitudinal population survey which includes the full SF-36 in every 12 month 
interview wave. In the HILDA study, respondents are also asked whether they 
have developed any long-term health problem or disability since last interview, 
responses to which provides an anchor of clinically important change [11, 15, 16]. 
 
Our aim in this paper was to calibrate the response categories of the HTQ to this 
anchor of clinically important change in health. We did this by comparing 
prospective change scores on the SF-36 scales for the group who had developed a 
new long-term condition since last interview with the prospective change scores 
for the MDD group of the HTQ. This approach takes the position that prospective 
change scores are the ‘gold-standard’ for measuring change since they are based 
on serial measures of current health status, and are therefore free from recall bias. 
We use them as an intermediary measure to calibrate the retrospective HTQ 
against the known change in clinical health. By calibrating the HTQ within a 
large Australian population study we anticipate that the clinical interpretation of 
the HTQ can be generalised to other population studies, in particular cross- 











The Household Income and Labour Dynamics of Australia (HILDA) study is a 
longitudinal population survey commenced in 2001. The HILDA respondents 
were drawn from a representative sample of Australian households. Follow-up 
waves of interviews are completed every 12 months. Details of the HILDA 
method and sample are published elsewhere [17]. At each interview wave 
respondents complete the Australian SF-36 Version 1 health survey [3]. 
 
We included respondents aged 18 years and over who completed the SF-36 health 




Changes in health status were measured in three ways. 
 
1) Prospective changes in health status were calculated as within-person changes in 
scores between baseline (Wave 1, 2001) and follow up (Wave 2, 2002) for each of 
the eight SF-36 scales. 
 
 
2) Retrospective change in health status was measured by responses to the SF-36 
HTQ in Wave 2. 
 
3) The external anchor of clinically important change was defined as the 
development at follow-up (Wave 2) of at least one new long-term health condition 
since the previous interview (baseline, Wave 1). The clinical anchor was derived 
from two questions in HILDA. Respondents were shown a list of conditions 
(detailed in the appendix) and asked: 
 
i) “Do you have any long-term health condition, impairment or disability 
(such as these) that restricts you in your everyday activities, and has lasted 
or is likely to last, for 6 months or more?” Response: Yes/no. 
 
ii) “Did you first develop [this condition / any of these conditions] after 




Respondents who answered yes to both questions on new conditions were 
classified as having experienced a clinically important change since the last 
interview and were included in the New Conditions group. 
 
Respondents who had not developed a new long term condition since last 
interview were then divided into five HTQ sub-groups according to their 
responses to the HTQ, ie ‘Much Better’ HTQ subgroup, ‘Somewhat Better’ 
subgroup, ‘The Same’ sub-group, ‘Somewhat Worse’ subgroup and ‘Much 
Worse’ subgroup. The New Conditions group formed the anchor against which 
we compared the HTQ subgroups. Excluding those with a new condition from the 




We compared the magnitude of prospective change scores on SF-36 scales for the 
New Conditions group with the change scores for each of the HTQ sub-groups 




Raw change scores were adjusted for comparability across groups using methods 
recommended by Husted and colleagues [10]. Firstly we used linear regression to 
calculate mean change scores for each group adjusted for age and gender. 
 
To calculate the mean change scores for the HTQ sub-groups we used the sub- 
sample of respondents without a new long term condition. 
 
We fitted a separate model for each SF-36 scale with change in SF-36 scale score 
as the dependent variable and each level of the HTQ question as the group 
variable, adjusted for age and gender. 
 
We repeated the analysis using the whole sample and fitted new long-term 
condition (yes or no) as the group variable to calculate the adjusted mean change 
in scale scores New Conditions group. 
 
The second measure we used to estimate change in scale scores was the 
standardised response mean (SRM) [10]. 
SRM = Unadjusted mean change in score/standard deviation of change scores. 
The SRM takes into account variability of change between persons by adjusting 
the mean change for within group variance. 
 
The adjusted mean changes and SRMs for the HTQ sub-groups were compared 
with those of the New Conditions group to calibrate the magnitude of change 
captured by responses to the HTQ relative to a a known clinically important 
change. 
 
To assess present state bias in the HTQ we examined the correlations between the 





There were 13,191 respondents 18 years and over in Wave 1, of whom 9,649 
(73%) completed the SF-36 health questionnaire in Waves 1 and 2. These 
individuals formed the sample for this paper. At baseline, their mean age was 45.7 
years, 53.4% were female, 50.7% reported being in very good or excellent health at 
baseline (Table 1). Respondents who dropped out after Wave 1 but who had 
completed the SF-36 in Wave 1 (n = 1329) were somewhat younger (mean age 
41.5 years) than the included sample, and a similar proportion had very good or 
excellent health at baseline (53.2%). The included sample and dropouts had the 
same rate of existing conditions at baseline (24.3% and 23.9%). 
 
At Wave 2, 3.6% (n=350) reported developing a new long-term health condition 
or disability since the last interview. These respondents (the New Conditions 
group) were older (mean age 55.4 years), and had poorer self-assessed health at 
baseline than did the group with no new long term condition (Table 1). Table 2 
shows the distribution of the HTQ for the whole sample, for the New Conditions 




across HTQ categories). In the New Conditions group, 55.7% reported their health 




TABLEs 1 and 2 about here 
 
******************************************************** 
Table 3 shows the correlation between the HTQ and baseline, follow-up and 
change scores. The correlations between the HTQ and change scores were 
positive but weak. Correlations with follow-up scores were weak to moderate. 
With baseline scores the correlations were very weakly positive. 
 
******************************************************** 





Table 4 compares the prospectively calculated SF-36 mean change scores of those 
with and without a new long-term health condition. The New Conditions group 
had a mean decline of 5 points or more and small to moderate negative SRMs for 
all scales except mental health[18]. In contrast, the average change in scale scores 
and SRMS were close to zero for the group without a new chronic health 
condition. When those without a new condition were analysed by HTQ category 
(Table 5), it can be seen that the mean change scores and SRMs follow the 
expected gradient, with the largest improvements and deteriorations being seen in 
the ‘much better’ and ‘much worse’ groups, respectively. The magnitude of the 
SRMs for the New Conditions group was similar in sign and magnitude to those 
of the ‘somewhat worse’ HTQ subgroup. 
 
Figure 1 shows the profile of mean changes in scale scores adjusted for age and 
gender. The profiles of change scores highlight the similarity between the New 
Conditions group and the ‘somewhat worse’ HTQ subgroup. These two groups 
only differed significantly in change scores for the physical function (p=0.004) 
and the role physical scales (p=0.03). Figure 1 also demonstrates the asymmetry 
in the magnitude of mean change scores on the HTQ. The negative mean changes 
of the ‘somewhat worse’ and ‘much worse’ subgroups were larger than the 
positive mean change of the corresponding ‘somewhat’ and ‘much better’ 
subgroups. 
 
(Note that the mean change scores in Tables 4 and 5 are unadjusted, while the 
change scores in Figure 1 are adjusted for age and gender. Adjustment did not 








In Tables 4 and 5, the standard deviations in change scores are large relative to the 
mean change for all the SF-36 scales. This means that a proportion of respondents 
who reported retrospective change in health status on the HTQ had prospective 
change scores that were in the opposite direction to their HTQ category. This is 




person) change scores for the general health scale for each of the HTQ sub-groups 
and for the New Conditions group. For example, of the 92 people who did not have 
a new health condition at Wave 2 and reported feeling much worse at Wave 
2, 75% had a negative change score (reflecting deterioration in their prospectively 
measured health consistent with their HTQ response), but the remaining 25% had a 
positive change score (reflecting improvement in their prospectively measured 
health, which was not consistent with their HTQ response). The same was true for 
the 949 people who reported feeling somewhat worse at Wave 2, as reflected in the 
location of the third quartile (upper edge of the box) of their distribution at the 
zero change line. Somewhat larger proportions of inconsistent observations were 
seen in the two HTQ improved groups (since the third quartiles of their 
distributions were below the zero change line). For the ‘no change’ HTQ 
subgroup, approximately 50% of the distribution was above or below zero. About 
50% of the individuals in this group had prospective change scores within about 
10 points of zero, but some individuals had quite large change scores, both 












Using data from the longitudinal HILDA study we calibrated the categories of the 
SF-36 health transition question against an external anchor of clinically important 
change in health by comparing the mean group differences in prospective within- 
person changes in the SF-36 scales. The mean change in scale scores of the group 
who did not report a new long-term health condition was close to zero for all SF- 
36 scales, while there was an appreciable negative mean change in scale scores for 
those who had recently developed a new long-term health problem. This 
demonstrated that the prospective measures of change were responsive to our 
selected anchor of known clinical change, a necessary pre-requisite for our 
proposed calibration method. For the sub-group who described their health as 
‘somewhat worse’ than one year ago, the mean changes in scores of the majority 
SF-36 scales, were in the vicinity of those of the New Conditions group. We 
interpret these findings as indicating that those who retrospectively reported their 
health as ‘somewhat worse’ than a year ago experienced a decline in health 
similar in magnitude to those who had developed a long-term health condition in 
the last year. These results therefore provide a clinical interpretation for the 
‘minimal detectable difference’ measured by the category ‘somewhat worse’ on 
the HTQ. 
 
Excluding respondents with a new long-term condition from the HTQ subgroups 
allowed a comparison of mutually exclusive groups. However the ‘somewhat 
worse’ HTQ sub-group lost the greatest proportion of respondents to the New 
Conditions group, since 44% of the New Conditions group reported their health as 
‘somewhat worse’ than a year ago. We note that the definition of the New 
Conditions group required that the condition was serious enough to affect daily 
activities, and that this definition has some overlap with items of both the physical 
function and role physical scales of the SF-36. Thus the larger declines on the 
physical functioning and role physical scales for those with a new condition 
relative to those who report their health as ‘somewhat worse’ may be an artefact of 
the removal of respondents with predominantly physical conditions from the HTQ 
sub-groups to the New Conditions group. Even within the ‘somewhat worse 
health’ subgroup the change profile still showed greatest declines on the physical 
scales which may indicate that when physical roles and functioning decline that is 
when respondents notice that their health has become worse 
 
Twenty three percent of the HTQ subgroups had an existing long-term condition 
at baseline. However existing conditions did not explain decline on the domain 
scales for the HTQ subgroups (results not shown) and the causes of decline in 
health status for those without a new long-term condition remain unexplained. 
 
 
Our results are based on a large and representative Australian population sample 
and add to what is known on the application of the SF-36 in population surveys 
[4, 9, 19] . Our findings indicate that, at least at the group level, the retrospective 
HTQ is a valid and useful question that can distinguish groups of respondents who 
improve from those who deteriorate. This makes the SF-36 HTQ a reasonable 
candidate for cross-sectional population surveys which require a measure of change 
in health status, and are looking for brief measures to reduce the response burden. 




a valid proxy for prospectively measured change in health is moderated by some 
important caveats. 
 
The variability in individual change scores indicates some level of misclassification 
using the HTQ. One potential source of misclassification is present state bias which 
our results demonstrated. Responses to the HTQ were positively correlated with 
follow up scale scores, but were NOT similarly negatively correlated with baseline 
scores, indicating that respondents were strongly influenced by their present health 
status when assessing recent changes in health status [6, 7]. The SF-36 HTQ may 
be prone to present state bias because it 
is based on a one-year recall period, whereas other HTQ are based on much 
shorter periods. The global nature of the HTQ may also increase the risk of bias, 
where multi-item domain-based transition questions may elicit more accurate 
recall [8]. 
 
However not all variability in change scores necessarily indicates 
misclassification. There was a similar amount of variability in the change scores 
for the New Conditions group. Less misclassification error would be expected in 
this more ‘objective’ clinical change group. Variability may be explained by the 
global question on new conditions that did not specify which new conditions the 
respondent had developed. Therefore change in health status for the New 
Conditions group would be expected to be heterogenous across domains which 
would contribute to the observed variability in change scores. New diagnosis may 
also result in improvement for some of this group as they respond to the 
commencement of treatment. 
 
Our results demonstrate that the HTQ is valid for describing the average clinical 
change in health status at the group level, and within group variability does not 
neccessarily disqualify the HTQ for this purpose. However the variability of 
change scores does indicate that the HTQ cannot reliably predict the magnitude of 
clinical change experienced by any particular individual, and if used to categorise 
individuals into groups be extent of change, a sizable proportion (but not a 
majority) will be misclassified. However, decline (or improvement) in health status 
in a single domain may prompt a respondent to consider his/her health has 
worsened (or improved) even if other domains change in the other direction and 
this could explain some of the variability in change scores on the other domains 
These limitation of the HTQ as a measure of change need to be acknowledged and 
taken into account, not only in the design of future health outcome surveys, but 




The clinical meaning of ‘somewhat worse health than a year ago’ may be context 
specific and may have different clinical meanings between clinical and general 
populations [20]. Nevertheless, the results presented in this paper contribute to our 
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Figure 1 Prospectively measured mean change scores1 for those with a new long term 
health condition (New Conditions) at Wave 2, and by HTQ subgroup at Wave 2 for those 
without a new long term condition. 
 
New Conditions 
20 much better 
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15 no change 
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1. Calculated from Wave 1 to Wave 2, adjusted for age and gender; 95% confidence intervals 
for the New Conditions group (n=350) and those without a new long term condition who 



















































































Figure 2 Box-and-whisker plot of distribution of change in general health scale scores for each HTQ 
sub-group (without a new long-term health condition) and for the group with a new long-term health 

























much better   somewhat better    no change    somewhat worse  much worse New Conditions 
 
The box = interquartile range, from the lower quartile (Q1) to the upper quartile (Q3), thus 
contains 50% of the observations. 
The lower whisker = Q1-1.5 x interquartile range 
The upper whisker = Q3+1.5 x interquartile range 
‘x’ indicates the mean 









Table 1: Respondent characteristics at baseline: total sample compared with respondents with 
those who developed a new long-term health condition at follow-up. 







n = 350 
% 
No New long- 
term health 














Baseline (Wave 1) 
Gender (% female) 52.3 53.5 53.4 
Mean age (years) at baseline 55.4 45.4 45.7 
Self-assessed health at baseline (missing = 98) 
Excellent 5.5 15.4 15.1 
Very Good 21.2 36.1 35.6 
Good 35.4 32.9 33.0 
Fair 29.0 12.6 13.2 
Poor 9.0 3.0 3.2 
Existing long-term health condition at baseline 48.0 22.9 23.8 
 
 
Table 2: Distribution of HTQ responses at follow up for those who reported a new long-term 
condition at follow up (New Conditions group) compared with those who did not develop a 
new long-term condition at follow-up. 
Respondent characteristics   New long-term 













N = 9,649 
% 
Follow up (Wave 2) 
Much better now than one year ago 2.0 (7) 4.8 (450) 4.7 
Somewhat better now than one year ago 8.3 (29) 11.1(1036) 11.0 
About the same as one year ago 34.0 (119) 72.8 (6772) 71.4 
Somewhat worse now than one year ago 44.0 (154) 10.2 (949) 11.4 




Table 3: Correlation between retrospective HTQ with baseline SF-36 scale scores, follow up 
scores and change in scale scores. 
SF-36 domains Correlation of  Correlation of HTQ± correlation of HTQ± with 
HTQ± with Wave 1 with Wave 2 SF-36 prospective change  in 









0.14 0.26 0.13 
0.15 0.30 0.21 
0.05 0.15 0.12 
0.16 0.26 0.16 
0.05 0.16 0.10 
0.12 0.28 0.17 
0.08 0.22 0.16 
0.11 0.25 0.17 
 
*Spearman rank correlation coefficients (all coefficients significant p < .0001) 
 
±Health Transition question coding has been reversed (ie. coded 5 for “much better” health than a year ago and 1 




Table 4: Unadjusted mean change (standard deviation, SD) in SF-36 scores over the 12 
months and standardised response mean (SRM) for respondents who had and had not 
developed a new long-term condition at follow-up. 
New Conditions group 
(n=350) 
No new condition 
(n = 9299) 
SF-36 domain Mean change 
(SD) 




general health -8.0 (19.0) -0.42 -0.5 (14.6) -0.03 
bodily pain -7.2 (29.8) -0.24 0.1 (22.1) 0.00 
mental health -2.5 (17.5) -0.14 0.1 (15.0) 0.01 
physical functioning -9.1 (25.7) -0.35 -0.1 (17.4) -0.01 
role emotional -7.0 (45.0) -0.16 1.1 (34.1) 0.03 
role physical -19.1 (45.3) -0.42 0.3 (33.9) 0.01 
social functioning -8.9 (28.9) -0.31 0.2 (22.7) 0.01 
vitality -5.3 (20.2) -0.26 -0.1 (16.6) -0.01 
pcs -5.4(11.3) -0.48 -0.1 (7.7) -0.01 
  mcs  -1.1(10.9)  -0.10  0.2 (9.2)  0.02   
 





Table 5: Prospectively measured mean change (standard deviation) in SF-36 domain scores over the 12 months 
and standardised response means for respondents without a new long-term condition by retrospective self-report 
on the health transition question 
Health transition 
category 
at Wave 2 
much better 
SF-36 domain Mean unadjusted 
change  (SD) 




(n = 450)                            general health                               6.4(17.7)                             0.36 
bodily pain                                     8.4(26.9)                             0.31 
mental health                                3.5(18.1)                             0.19 
physical functioning                     3.5(19.5)                             0.18 
role emotional                               8.4(41.7)                              0.2 
role physical                                 12.7(38.4)                            0.33 
social functioning                         7.8(27.9)                             0.28 
vitality                                             6.5(19.0)                             0.34 
pcs                                                   2.8(9.0)                              0.31 
mcs 2.7(11.1)                             0.24 
somewhat better 
(n = 1036)                          general health                               2.7(15.1)                             0.18 
bodily pain                                     3.5(21.9)                             0.16 
mental health                                2.9(15.8)                             0.18 
physical functioning                     1.8(18.8)                             0.09 
role emotional                               5.7(36.7)                             0.16 
role physical                                    5(35.1)                               0.14 
social functioning                         3.7(23.7)                             0.16 
vitality                                             3.9(16.9)                             0.23 
pcs                                                   0.8(8.1)                              0.10 
mcs 1.9(10)                               0.19 
about the same 
(n = 6772)                          general health                              -.19(13.4)                            -0.01 
bodily pain                                     0.2(21.1)                             0.01 
mental health                                0.2(14.0)                             0.01 
physical functioning                     0.3(16.5)                             0.02 
role emotional                               1.2(30.5)                             0.04 
role physical                                  0.9(31.4)                             0.03 
social functioning                         0.6(21.0)                             0.03 
vitality                                               0(15.5)                               0.00 
pcs                                                   0.1(7.1)                              0.01 
mcs 0.2(8.4)                              0.02 
somewhat worse 
(n = 949)                            general health                              -8.8(16.1)                            -0.54 
bodily pain                                    -6.8(24.0)                            -0.29 
mental health                               -3.9(17.0)                            -0.23 
physical functioning                    -5.1(19.0)                            -0.27 
role emotional                              -6.5(45.5)                            -0.14 
role physical                                -13.8(41.6)                           -0.33 
social functioning                         -7.9(26.0)                            -0.30 
vitality                                            -6.7(18.4)                            -0.36 
pcs                                                  -3.3(9.2)                             -0.36 
mcs -2.8(11.0)                            -0.25 
much worse 
(n = 92)                              general health                             -14.1(20.8)                           -0.68 
bodily pain                                   -14.5(28.1)                           -0.52 
mental health                              -11.3(21.4)                           -0.53 
physical functioning                   -14.1(25.7)                           -0.55 
role emotional                             -19.8(53.0)                           -0.37 
role physical                                -21.4(44.0)                           -0.49 



















SHOWCARD:  List of chronic conditions shown to respondents 
DISABILITIES/ HEALTH CONDITIONS WHICH: 
• Have lasted 6 months or more, 
• Restrict everyday activity, and 
• Can not be corrected by medication or medical aids 
 
• Sight problems not corrected by glasses or contact lenses 
• Hearing problems 
• Speech problems 
• Blackouts, fits or loss of consciousness 
• Slow at learning or understanding things 
• Limited use of arms or fingers 
• Difficulty gripping things 
• Limited use of feet or legs 
• Nerves or emotional conditions which require treatment 
• Any restriction on physical activity or physical work 
• Any disfiguration or deformity 
• Any mental illness which requires help or supervision 
• Long term effects as a result of a head injury, stroke or other 
brain damage 
• A long-term condition or ailment which is still restrictive even 
though it is being treated or medication is being taken for it 
• Any restriction caused by Arthritis, Asthma, Heart Disease, 
Alzheimer’s Disease, Dementia or any other long-term condition 
 
Source: http://www.melbourneinstitute.com/hilda/qaires/ShowcardsW2.pdf 
